Print PDF

Bioscience Investor Outlook: 2016 Trend Report and 2017 Projections

Presented by CURE @ BioHaven

September 28, 2016
Anlyan Center at Yale University, New Haven, Connecticut

CURE presents a deeply experienced panel of bioscience investors as they explain the venture capital trends of 2016 as well as discuss a look into the future as to where the capital will be flowing in 2017.  Hosted by Harry Penner, Director, CURE and moderated by Dormer Stephen, Partner, Shipman & Goodwin, panelists include Christy Shaffer, General Partner, Hatteras Venture Partners, Kevin Rakin, Co-Founder of HighCape Partners, Tim Shannon, General Partner, Canaan Partners, Mark Dempster, Managing Director, Stifel, Nicolaus, Weisel and one additional panelist will lead this exciting conversation regarding bioscience investing, helping our region cultivate and advance biomedical innovation and services to support new medical advances.